Galaxy Medicare Limited (NSE: GML) is a Bhubaneswar, Odisha-based company in the Medical Consumables industry. With a market capitalisation of ₹26 Cr, it ranks #4,241 by market cap among the 6,197 Indian listed companies on FinBizNet, and #12 of 14 in Medical Consumables. At ₹17.35 (as of 19 Nov 2026), the share price is 3.3% below its 52-week high of ₹17.95 and 0.3% above its 52-week low of ₹17.30.
| Current Price | ₹17.35 |
|---|---|
| Market Cap | ₹26 Cr |
| NSE Symbol | GML |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Supplies > Medical Consumables |
| P/E Ratio | 6.9 |
| Return on Equity | 8.48% |
| Return on Assets | 6.71% |
| 52-Week Range | ₹17.30 – ₹17.95 |
| Beta (1Y) | 0.62 |
| Dividend Yield | 4.03% |
| Headquarters | Bhubaneswar, Odisha |
| Website | www.galaxy.in |
Promoters held 72.98% of Galaxy Medicare Limited's shares as of Mar 2026, against 72.43% in Sept 2025 (+0.55 percentage points).
Galaxy Medicare Limited engages in manufacturing, trading, and exporting medical devices and surgical products in India and internationally. The company offers plaster of Paris bandage and orthopedic casting tape; surgical dressing, such as streile antiseptic tulle-grass dressing, sterile paraffin gauze dressing, hypoallergenic surgical tape, and sterile combine dressing; adhesive tape U.S.P; and elastic adhesive bandage, orthopaedic wool bandage, cotton crepe bandage, and cannula fixator. It serves its products under the POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, and FIXCAN brand names. Galaxy Medicare Limited was incorporated in 1992 and is based in Bhubaneswar, India.
1. Medical Products-This segment engages in manufacturing, trading, and exporting medical devices and surgical products comprising Plaster of Paris bandage, medical tapes and bandages, and other surgical dressings, as well as external preparations products of wound care and wound management, including sterile surgical wound dressing, medical disposable, adhesive bandages, absorbent gauze, medical kits, etc. 2. NA-NA 3. NA-NA 4. NA-NA
1. Medical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Poly Medicure Ltd. | ₹17,162 Cr | 53.3 | 10.84% | ₹581 Cr | -14.5% |
| Sahajanand Medical Technologies | ₹4,899 Cr | 77.9 | — | ₹373 Cr | — |
| Q-Line Biotech Limited | ₹1,280 Cr | 15.7 | 22.63% | — | — |
| Laxmi Dental Limited | ₹1,128 Cr | 39.3 | 12.77% | ₹80 Cr | -38.2% |
| Prevest Denpro Ltd | ₹502 Cr | 24.6 | 17.79% | — | -22.6% |
| Choksi Imaging Ltd. | ₹119 Cr | 22.3 | 13.51% | — | +94.0% |
| GSM Foils Limited | ₹72 Cr | 3.9 | 37.54% | ₹97 Cr | -78.3% |
| Mohini Health & Hygiene Ltd | ₹51 Cr | n/m | -17.18% | — | -41.2% |
| Galaxy Medicare Limited | ₹26 Cr | 6.9 | 8.48% | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Galaxy Medicare Limited is trading at ₹17.35, with a market capitalisation of ₹26 Cr.
Galaxy Medicare Limited operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Supplies > Medical Consumables).
Galaxy Medicare Limited has a P/E of 6.9 and a return on equity of 8.48%.
Galaxy Medicare Limited is listed on the NSE under the symbol GML.
Promoters held 72.98% of Galaxy Medicare Limited's shares as of Mar 2026, against 72.43% in Sept 2025 (+0.55 percentage points).
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.